A common MET polymorphism harnesses HER2 signaling to drive aggressive squamous cell carcinoma. - Kong LR; Mohamed Salleh NAB; Ong RW; Tan TZ; Syn NL; Goh RM; Fhu CW; Tan DSW; Iyer NG; Kannan S; Verma CS; Lim YC; et al. (Nature communications, 2020)